[Treatment Strategies for Septic Arthritis of the Sternoclavicular Joint].
Septic arthritis of the sternoclavicular joint (SCJ) is a relatively rare disease. Due to serious complications including mediastinitis and generalised sepsis early diagnosis and rapid onset of treatment are mandatory. The disease often affects immunocompromised patients, diabetics, or patients with other infectious diseases. The therapeutic options range from administration of antibiotics to extended surgery including reconstructive procedures. Apart from rare situations where conservative treatment with antibiotics is sufficient, joint resection followed by plastic surgical procedures are required. We present a retrospective analysis with data from two hospitals. From January 2008 to December 2012 23 patients with radiographically confirmed septic arthritis of various aetiology were included. Fourteen (60.8 %) male, nine (39.2 %) female patients with an average age of 60.3 ± 14.2 years (range: 23-88 years) with septic arthritis of the SCJ were treated. Seven (30.4 %) patients suffered from Diabetes mellitus, nine (39.1 %) had underlying diseases with a compromised immune system. In 14 (60.8 %) out of 23 patients a bacterial focus was detected. Only six (26 %) patients suffered from confined septic arthritis of the SCG, in 17 (73,9 %) patients osteomyelitis of the adjacent sternum, and the clavicle was present. In addition, 15 (65.2 %) patients already suffered from mediastinitis at the time of diagnosis, eight (35 %) patients even from septicaemia. In conclusion, septic arthritis requires an active surgical treatment. Limited incision of the joint and debridement alone is only successful at early stages of the disease. The treatment concept has to include the local joint and bone resection as well as complications like mediastinitis. After successful treatment of the infection, the defect of the chest wall requires secondary reconstructive surgery using a pedicled pectoralis muscle flap.
Klinik für Allgemein-, Viszeral-, Thorax- und minimalinvasive Chirurgie, Siloah St. Trudpert Klinikum, Pforzheim, Deutschland.
O
O
Kuhtin
Klinik für Orthopädie und Unfallchirurgie, Siloah St. Trudpert Klinikum, Pforzheim, Deutschland.
B
B
Schmidt-Rohlfing
Institut für Diagnostische und Interventionelle Radiologie, Siloah St. Trudpert Klinikum, Pforzheim, Deutschland.
M
M
Dittrich
Abteilung Thoraxchirurgie, Klinik für Herz- und Thoraxchirurgie, Augsburg, Deutschland.
L
L
Lampl
Klinik für Thoraxchirurgie, HELIOS Klinikum Krefeld, Deutschland.
M
M
Hohls
Klinik für Thoraxchirurgie, HELIOS Klinikum Krefeld, Deutschland.
V
V
Haas
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D002968:Clavicle / Q000000981:diagnostic imaging / Q000601:surgery; D003131:Combined Modality Therapy; D042241:Early Diagnosis; D061345:Early Medical Intervention; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D008297:Male; D008371:Manubrium / Q000000981:diagnostic imaging / Q000601:surgery; D008875:Middle Aged; D010019:Osteomyelitis / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D035583:Rare Diseases; D012189:Retrospective Studies; D013247:Sternoclavicular Joint / Q000000981:diagnostic imaging / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D055815:Young Adult
D000900:Anti-Bacterial Agents